DUXAP9 and urinary bladder cancer: Furthermore, LNMAT1-induced CCL2 expression by bladder cancer cells recruited TAMs, which participated in the pro-lymphangiogenic process via VEGF-C excretion and ultimately contributed to lymphangiogenesis and lymphatic metastasis.